Desogestrel-only contraception may reduce headache frequency and improve quality of life in women suffering from migraine

REFERENCES

• Hagen K, Zwart JA, Vatten L, et al. Prevalence of migraine and non-migrainous headache – head-HUNT, a large population-based study. Cephalalgia 2000;20:900–6.
   PubMed Web of Science ®Google Scholar
• Macgregor EA, Rosenberg JD, Kurth T. Sex-related differences in epidemiological and clinic-based headache studies. Headache 2011;51:843–59.
   PubMed Web of Science ®Google Scholar
• Peterlin BL, Gupta S, Ward TN, Macgregor A. Sex matters: Evaluating sex and gender in migraine and headache research. Headache 2011;51:839–42.
   PubMed Web of Science ®Google Scholar
• Macgregor EA. Menstrual migraine: A clinical review. J Fam Plann Reprod Health Care 2007;33:36–47.
   PubMed Web of Science ®Google Scholar
• Somerville B. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972;22: 355–65.
   PubMed Web of Science ®Google Scholar
• Aegidius K, Zwart JA, Hagen K, et al. Oral contraceptives and increased headache prevalence: The Head-HUNT Study. Neurology 2006;66:349–53.
   PubMed Web of Science ®Google Scholar
• Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: Case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ 1999;318:13–8.
   PubMed Web of Science ®Google Scholar
• Bigal ME, Kurth T, Santanello N, et al. Migraine and cardiovascular disease: A population-based study. Neurology 2010;74:628–35.
   PubMed Web of Science ®Google Scholar
• Tzourio C, Tehindrazanarivelo A, Iglesias S, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995;310:830–3.
   PubMed Web of Science ®Google Scholar
• Schurks M, Buring JE, Kurth T. Migraine, migraine features, and cardiovascular disease. Headache 2010;50: 1031–40.
   PubMed Web of Science ®Google Scholar
• Curtis KM, Mohllajee AP, Peterson HB. Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: A systematic review. Contraception 2006;73:189–94.
   PubMed Web of Science ®Google Scholar
• Tzourio C, Iglesias S, Hubert JB, et al. Migraine and risk of ischaemic stroke: A case-control study. BMJ 1993;307:289–92.
   PubMed Web of Science ®Google Scholar
• Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives: A meta-analysis. JAMA 2000;284:72–8.
   PubMed Web of Science ®Google Scholar
• Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: National follow-up study. BMJ 2009;339: b2890.
   PubMed Web of Science ®Google Scholar
• Barkfeldt J, Virkkunen A, Dieben T. The effects of two progestogen-only pills containing either desogestrel (75 microg/day) or levonorgestrel (30 microg/day) on lipid metabolism. Contraception 2001;64:295–9.
   PubMed Web of Science ®Google Scholar
• Rice C, Killick S, Hickling D, Coelingh Bennink H. Ovarian activity and vaginal bleeding patterns with a desogestrel-only preparation at three different doses. Hum Reprod 1996;11:737–40.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: The Migraine Disability Assessment (MIDAS) questionnaire. Headache 2001;41:854–61.
   PubMed Web of Science ®Google Scholar
• Stewart WF, Lipton RB, Kolodner KB, et al. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain 2000;88:41–52.
   PubMed Web of Science ®Google Scholar
• Silberstein SD. Preventive migraine treatment. Neurol Clin 2009;27:429–43.
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen P, Olesen J. Taking the negative view of current migraine treatments: The unmet needs. CNS Drugs 2012;26:375–82.
   PubMed Web of Science ®Google Scholar
• Lidegaard Ø, Løkkegaard E, Jensen A, et al. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012;366:2257–66.
   PubMed Web of Science ®Google Scholar
• Schurks M, Rist PM, Bigal ME, et al. Migraine and cardiovascular disease: Systematic review and meta-analysis. BMJ 2009;339:b3914.
   PubMed Web of Science ®Google Scholar
• Wober C, Brannath W, Schmidt K, et al. Prospective analysis of factors related to migraine attacks: The PAMINA study. Cephalalgia 2007;27:304–14.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Sances G, Allais G, et al. Effects of an estrogen-free, desogestrel-containing oral contraceptive in women with migraine with aura: A prospective diary-based pilot study. Contraception 2011;83: 223–8.
   PubMed Web of Science ®Google Scholar
• Sulak P, Willis S, Kuehl T, et al. Headaches and oral contraceptives: Impact of eliminating the standard 7-day placebo interval. Headache 2007;47:27–37.
   PubMed Web of Science ®Google Scholar
• De Leo V, Scolaro V, Musacchio MC, et al. Combined oral contraceptives in women with menstrual migraine without aura. Fertil Steril 2011;96:917–20.
   PubMed Web of Science ®Google Scholar
• Calhoun AH. Menstrual migraine: Update on pathophysiology and approach to therapy and management. Curr Treat Options Neurol 2012;14:1–14.
   PubMed Web of Science ®Google Scholar
• Calhoun A, Ford S, Pruitt A. The impact of extended-cycle vaginal ring contraception on migraine aura: A retrospective case series. Headache 2012;52:1246–53.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343–9.
   PubMed Web of Science ®Google Scholar
• Hawkins K, Wang S, Rupnow M. Direct cost burden among insured US employees with migraine. Headache 2008;48:553–63.
   PubMed Web of Science ®Google Scholar